Skip to main content
The Breast : Official Journal of the European Society of Mastology logoLink to The Breast : Official Journal of the European Society of Mastology
. 2026 Jan 20;86:104705. doi: 10.1016/j.breast.2026.104705

“You're really walking along the razor's edge”: A meta-synthesis on the existential cost of breast cancer related to financial toxicity

Sara Paltrinieri a, Margherita Schiavi a,b,, Barbara Bressi a, Angela Contri c, Martina Torreggiani a, Laura Bernardi d, Elisa Mazzini e, Maria Chiara Bassi f, Silvia di Leo g, Luca Ghirotto h, Stefania Costi a,i
PMCID: PMC12860959  PMID: 41579560

Abstract

Cancer-related financial toxicity (FT) is a challenge of living with and beyond breast cancer (BC). A systematic review and meta-synthesis was conducted to report the experience of individuals with BC regarding cancer-related FT. Data were searched in MEDLINE, Embase, Cinahl, Scopus, PsycINFO, and Web of Science from inception. Eligibility was restricted to original qualitative studies. We performed a meta-synthesis by generating interpretative themes and a model of cancer-related FT. Thirty-two studies were included, encompassing 1080 individuals with BC. Of these studies, 17 were conducted in North America (719 individuals), nine in South, East, and West Asia (238 individuals), two in Oceania (53 individuals), and four in Northwest Africa (70 individuals). Five themes were identified: (i) the existential cost of cancer, (ii) the impact of insurance complexity, (iii) the need for timely and accessible information, (iv) seeking possible help, (v) negotiating daily life. The review highlights the lack of original qualitative studies conducted in Europe. Socioeconomic status, insurance, and employment amplify inequalities and shape the experience of FT. The interpretative model could support individuals with BC and providers’ communication.

Keywords: Breast neoplasms, Cancer-related financial toxicity, Qualitative research, Systematic review, Meta-synthesis

Graphical abstract

Image 1

Highlights

  • Individuals with breast cancer experience cancer-related financial toxicity.

  • We provided an interpretative model to describe their experiences.

  • This model improves communication between patients and professionals.

  • Tailored information and a navigator of economic aspects are patients' needs.

  • Primary qualitative studies across European countries are needed.

1. Introduction

Breast cancer (BC) is the second most frequent tumour worldwide, with 2.3 million new cases and eight million prevalent cases in 2022 [1]. BC is the third tumour type with the highest economic costs and the first one in females [2]. Early diagnostic methods, effective treatments, and changes in population growth will contribute to the progressively increasing trend [1].

Cancer-related financial toxicity (FT) is a major challenge for individuals living with and beyond BC [3]. Defined as both objective financial burden and subjective distress from cancer treatment [4,5], FT can affect access to care [6], financial stability, and overall health [7]. It involves out-of-pocket medical expenses, non-medical costs like transportation, and income loss due to sick leave and/or job loss [8]. FT varies by country, depending on the healthcare system characteristics, such as coverage, out-of pocket costs, and social protection mechanisms [9]. For example, the lack of universal coverage shifts costs to patients, often resulting in financial hardship or increased reliance on family and social support networks. Moreover, while FT is more common in low- and middle-income countries, over 30 % of individuals with BC in high-income countries also report FT [9]. Psychological effects, such as anxiety, fear of bankruptcy, and guilt over burdening family, can worsen FT [10], especially when caregivers lose income [11]. FT often leads to coping strategies like cutting essential spending [12] or skipping care [11].

Although cancer type is not a clear FT risk factor [9], individuals with BC may face greater financial needs due to prolonged multimodal treatments and heterogeneous side effects [10], such as lymphedema [11] or the need for breast reconstruction [12]. Furthermore, individuals with BC who are younger in age, have Hispanic ethnicity in the United States context, lower income [13,14], and are migrants [15] seem to have a higher risk of FT. Moreover, as compared to their male counterparts, females have a lower employment rate, particularly in low-income countries, work fewer hours per week on average, which affects their incomes [16], and are at higher risk of unemployment [17]. These social disparities are further exacerbated by the unequal distribution of non-paid work (i.e., household management, children) [18].

Over the past decades quantitative and qualitative studies have addressed cancer-related FT in individuals with BC [19,20]. Although qualitative research explores complex experiences shaped by social and cultural factors, no systematic review has focused on the broad lived experience of cancer-related FT and its daily impact on individuals with BC.

Gathering patients’ perspectives from diverse contexts can reveal the deeper meaning of cancer-related FT. Understanding their experiences is imperative to plan tailored interventions to reduce FT.

This systematic review and meta-synthesis addressed the following research questions: i) what is the experience of individuals with BC concerning their cancer-related FT? and ii) what are the reported consequences on daily life?

We aimed to synthetize the experiences of living with the cancer-related socioeconomic consequences from the perspectives of individuals with BC.

2. Methods

2.1. Search strategy and selection criteria

This systematic review and meta-synthesis is reported according to the ENTREQ guidelines (Appendix A, p 1) [21]. It was prospectively registered in PROSPERO (CRD42024534127). Bibliographic search was pre-planned and conducted by an information specialist (M.C.B.), a qualitative methodologist (L.G.), and two healthcare professionals (S.P. and S.C.). The search strategy (Appendix B, p 3) was customized for the electronic databases MEDLINE, Embase, Cinahl, Scopus, PsycINFO, and Web of Science, and they were searched from inception to May 2025. Filters were not applied. Records were also identified through citation searching. We included studies involving adult individuals (≥18 years) diagnosed with BC, regardless of disease stage or survivorship phase, that reported findings on cancer-related FT and its impact on daily life. We included any original study using either a primary or secondary data analysis in which qualitative methodology was used to collect data. We excluded studies with mixed cancer populations and mixed method studies when it was not possible to clearly identify the voice of individuals with BC or to extract the qualitative data, respectively. We excluded studies that were not published in English.

Three researchers (S.P., B.B., and M.T.) conducted title and abstract screening using Rayyan to manage the process [22], and any disagreement was resolved with S.C.

2.2. Quality assessment

The methodological quality of the included reports was assessed independently by two reviewers (S.P. and L.B.), and any disagreement was resolved with S.C. Appraisal was performed by using the Critical Appraisal Skills Program (CASP) checklist for qualitative research [23,24]. This checklist assesses the methodological quality of qualitative studies based on eleven criteria, including the validity of findings, appropriateness of the qualitative methodology and study design, recruitment strategy, theoretical framework, data collection methods, researcher-participants’ relationship, ethical considerations, data analysis, clarity of results, and the overall value of the research. The CASP checklist provides an overall quality level with no cutoff score.

2.3. Healthcare system contextualization

We framed the included reports within macro-structural contexts according to the widely accepted categorization proposed by Bohm et al. (2013) grounded in the theoretical assumptions developed by Wendt et al. (2009) to define healthcare system models [25,26]. The framework is primarily based on financing and healthcare coverage, two pillars of the regulatory dimension, one of the key criteria used to classify healthcare systems. Coverage refers to the inclusion of the population, in whole or in part, within public and/or private healthcare systems, while financing refers to the funding of healthcare through public and/or private sources. Included reports were framed in the following macro-structural contexts:

  • private health system is predominantly coordinated by private market actors, does not guarantee universal coverage, and relies on fragmented private insurance schemes or out-of pocket payments;

  • national health system is predominantly based on universal health coverage, with residual out-of-pocket costs. Although formal coverage exists, indirect payments and services not covered by the system persist,

  • under-resourced or poorly institutionalized health system is characterized by limited social protection and a high reliance on informal networks.

This categorization was intended as a contextual framework to support the interpretation of the findings, acknowledging that participants' experiences of FT are shaped by, though not explicitly articulated in terms of, these macro-structural factors.

2.4. Data extraction and meta-synthesis

Data were extracted independently by three authors (S.P., S.C, and L.B.), who agreed in advance on the information to be selected. The following data were extracted from each of the included reports: country of origin and healthcare system, journal title, study's aim(s) and design, recruitment setting, sampling strategy, data collection period, strategy and setting, data analysis, summary of findings, and sample characteristics.

In the context of this systematic review, we adopted a meta-synthesis approach to synthesize data, consistent to produce an interpretative integration and re-elaboration of qualitative findings from original studies. Meta-synthesis is a well-established methodology that transcends the mere aggregation of findings, instead offering a higher-order conceptualization through which novel interpretative insights can emerge [[27], [28], [29]]. Given the complexity and multifaceted nature of cancer-related FT, which intersects with structural, psychological, and relational domains, an interpretative approach was necessary to capture the depth and nuance of participants’ experiences. The phenomenon of FT in individuals with BC is not reducible to financial burdens alone, but involves identity negotiations, existential distress, and socio-economic inequalities. Thus, a meta-synthesis allowed us to move beyond listing barriers or coping mechanisms, and instead to identify deeper, latent constructs that shape how individuals experience, make sense of, and respond to FT.

To perform the meta-synthesis, both the quotes of individuals with BC (first order constructs) and the interpretation of the authors (second order constructs) of each original study were considered for extraction. The quotes reported under the headings “results” of each study were manually extracted and reported in an Excel table. During a meeting, S.P., B.B., M.S., A.C., and S.C. collaboratively coded the quotes of two original studies using line-by-line coding of the first and second order constructs to identify labels. Then, a third study was coded independently, and labels compared. The remaining studies were coded independently into existing or new labels. Subthemes and themes were inductively established by grouping labels and interpreting their meanings into a interpretative model. Disagreements were resolved with L.G. and S.D.L. The dataset is available in the repository.

3. Results

The PRISMA flowchart (Fig. 1) reports retrieval and screening process. We retrieved 938 records from the selected databases. After removal of duplicates, 500 titles and abstracts were screened, of which 40 reports were sought in full text. Sixteen additional reports were identified through citation searching. Full-text reports were assessed for eligibility, of which 24 were excluded. The latter are referenced in appendix C (p 5) together with the reasons for their exclusion.

Fig. 1.

Fig. 1

PRISMA flowchart.

Table 1 summarizes data collected from the 32 studies included, which were conducted in Australia [30,31], Canada [32], China [33], Egypt [34], Ghana [35], India [[36], [37], [38]], Indonesia [39], Iran [40], Malaysia [41], Nigeria [42,43], Pakistan [44], the USA [[45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60]], and Vietnam [61]. Twenty-four studies were qualitative [[30], [31], [32], [33],35,36,[39], [40], [41], [42], [43], [44], [45], [46],[49], [50], [51], [52], [53],55,[57], [58], [59], [60]], while seven had a mixed methods design [34,37,38,47,48,54,56], and one was an ethnography [61]. Five studies restricted eligibility to individuals with metastatic BC [31,39,53,58,60]. Sixteen studies used purposive sampling [32,36,37,39,40,42,43,[47], [48], [49],[51], [52], [53],55,57,59,60], six used convenience sampling [34,38,41,45,50,56], and five used mixed methods sampling designs [30,31,33,35,44,61]. Most studies used the individual semi-structured interview to collect data [30,31,[33], [34], [35], [36], [37],39,40,[42], [43], [44],[47], [48], [49], [50], [51],53,54,[56], [57], [58], [59], [60]]. A few other studies used focus group [32,38,41,45,46] or a mixed methods data collection modality [52,55,61].

Table 1.

Study characteristics.

First author
Country and Healthcare system
Journal title
Aim(s) of the study
Study design
Recruitment setting
Eligibility criteria
Sampling strategy
Data collection period
Data collection strategy
Data collection setting
Data analysis
Summary of findings
Inclusion Exclusion
Ko (2025) USA
Private health system
BMC Women's Health to explore financial toxicity, relating to what worsens the financial situation and its impacts, from the perspectives of Latina BC patients, family caregivers, and healthcare professionals qualitative local community organization using the patient database and referrals from local oncology clinics diagnosed with BC within the past five years, self-identified Latina, ≥18 years ·· purposive Nov 2022–Jun 2023 in-depth interview mixed (remote or in presence) thematic analysis employment disruption, medical-related and non-medical related financial costs, struggle to meet basic needs and experienced psychological distress, coordinating patient support care to accommodate their financial needs negatively impacted their families' work schedules and routines, affecting family relationships
Marshall (2025) USA
Private health system
Nursing Research to examine the lived experiences of women diagnosed with metastatic BC in the realm of financial concerns and unmet support needs specific to their cancer treatment qualitative designated cancer center located in southern United States metastatic BC, ≥18 years, English speaking ·· purposive ·· semi-structured interview remote (telephone or video call) thematic analysis Financial toxicities (costs of cancer treatments and medications, limitations of health insurance, effect on employment); unmet support needs (managing usual responsibilities, emotional, community and organizational support)
Do (2024) Vietnam
Poorly institutionalized system
Social Science & Medicine to examine how BC patients manage the financial burden of cancer care in Vietnam ethnographic Oncology Centre of Hue Central Hospital ·· ·· mixed (snowball and convenience) Apr–Dec 2019 mixed (observation, interviews, focus groups) presence grounded theory approach in a context where health-related risk protection is poorly organized and out-of-pocket expenses are burdensome, despite the presence of universal health coverage, patients must rely heavily on informal arrangements to finance their treatment, proactively researched available information and undertook extensive and ramified work to prove their deservingness for some types of assistance (strategically disclosing cancer)
Jones (2024) USA
Private health system
Future Science to refine the conceptual model of financial hardship after cancer qualitative Survivorship Program at anNCI-designated Comprehensive Cancer Center diagnosed with BC, ≥18 years, being at least 3 months post-diagnosis, able to read and speak English and to provide informed consent, located in the USA ·· convenience (participants were recruited among 162 women who consented to be contacted about future studies) ·· semi-structured interview remote (telephone or video call) deductive framework approach financial hardship: protective factors
included good health insurance, work accommodations and social support. Participants worried about cancer care costs and employment. Programs for alleviating financial hardship had high administrative
burdens
Khajoei (2024) Iran
Poorly institutionalized system
BMC Cancer to investigate the needs and experiences of breast cancer survivors qualitative University Hospital in Tehran women diagnosed with BC, 18–60 years, who had completed their treatment courses between four and 18 months prior, non-metastatic cancer, and stable clinical conditions cancer recurrence or metastasis, secondary cancers, and cognitive impairment purposive Apr–Jul 2023 semi-structured interview mixed (remote or in presence) Inductive content analysis financial toxicity, family support, informational needs, and psychological and physical issues
Patra (2024) India
Poorly institutionalized system
Cureus to examine the burden of financial hardship the causes and repercussions among BC survivors. mixed methods Indian Breast Cancer Survivorship Conference ·· ·· convenience (participants were recruited among 150 BC survivors who attended the conference) Oct 2023 focus group presence thematic framework Financial challenges, unemployment, borrowed money, treatment-related financial issues, financial insufficiency, discontinued treatment, insurance disparities and coverage, information and awareness, financial literacy
Ruan (2024) China
National health system
Supportive care in cancer to delve into the coping process amidst financial toxicity among young women with breast cancer qualitative Fudan University Shanghai Cancer Center diagnosis of BC, 18–40 years, completion of primary treatment and health condition was stable severe systemic conditions, ECOG score of 3–5, psychiatric disorders, hearing or expression barriers, identified by medical documents or observed by researchers during initial communication mixed (purposive and theoretical) Sept 2021–Jan 2022 semi-structured interview in presence Strauss & Corbin's constant comparative analysis financial toxicity is related to risk factors, coping resources, and unmet needs. To overcome financial toxicity,
participants adjusted by reshaping consumption concept, re-dividing of family functions, re-planning
of occupation career, and rebuilding life confidence
Waters (2024) USA
Private health system
Cancer Causes & Control to understand patients' lived experiences of financial burden, accessing financial assistance, and cost-coping mechanisms qualitative fliers in the breast cancer clinic, restrooms, and other areas within an academic medical center in the Southeast and clinical staff patients = diagnosed with metastatic BC, ≥18 years, spoke English, reported having experienced financial burden
caregiver = study enrollment was expanded to include caregivers acting as proxies on behalf of patients
·· ·· Jan–Jul 2019 semi-structured interview mixed (remote or in presence) descriptive phenomenological
approach to thematic analysis
causes of financial burden, financial assistance mechanisms, health insurance and financial burden, and cost-coping behaviors
Khazi (2023) India
Poorly institutionalized system
Clinical Epidemiology and Global Health to explore the psychosocial impact of breast cancer diagnosis on women in North Karnataka and the coping strategies adopted by them qualitative Belgaum Cancer Hospital women diagnosed with BC and undergoing treatment ·· purposive ·· semi-structured interview in presence interpretative phenomenological analysis psychological effects at diagnosis: stress and uncertainty, financial distress, family distress, and social withdrawal.
Family support and religious belief were the main coping strategies
Kolawole (2023) Nigeria
Poorly institutionalized system
African Journal of Reproductive Health to explore the lived experience of breast cancer patients at the General Hospital, Ilorin, Kwara State, Nigeria qualitative General Hospital Ilorin, Kwara State patients with BC, ≥30 years, have completed the initial treatment or fully completed treatment ·· purposive Dec 2021–Feb 2022 semi-structured interview in presence Tesch's content analysis approach using open coding disease's socioeconomic impact includes poor human relations, negative perceptions of breast cancer diagnosis, poor sociocultural roles, and negative effects on patients' livelihood
Lee (2024) USA
Private health system
Supportive care in cancer to reduce the gap of limited research by characterizing and describing treatment-related FT through the lived experiences of younger, rural, Black, and low-income women diagnosed with breast cancer qualitative National Cancer Institute Designated Comprehensive Cancer Center stage I–IV breast cancer, ≥18 years, received at least one primary cancer treatment modality (e.g., surgery, chemotherapy, radiation therapy, and/or endocrine therapy) ·· purposive Sept 2021–Mar 2022 mixed (group and individual interview) remote (telephone or video call) descriptive coding and thematic
analysis
short-term and long-term impacts of financial toxicity
Neilson (2023) USA
Private health system
Journal of Surgical Research to characterize contributors to financial distress in breast cancer patients, to assess resources used to combat financial toxicity, and to determine the preferred timing of education regarding potential financial effects of treatment mixed methods academic institution invasive BC or ductal carcinoma in situ ·· ·· Oct–Dec 2020 semi-structured interview remote (telephone or video call) grounded theory
methodology
contributors
to financial distress: unexpected medical and nonmedical expenses, lost
revenue from missed work, and altered budgeting
Walton (2023) India
Poorly institutionalized system
Indian Journal of Palliative Care to explore the experiences of adult female cancer survivors, to discover and describe common protective resilience factors that helped them to cope with the cancer experience and to identify the barriers to resilience mixed methods Cancer Survivors and Healthcare Personnel BC survivors, 18–70 years, had completed treatment, symptom free for the past 3 months and not exceeding 3 years metastasis, terminally ill and with comorbidities purposive ·· semi-structured interview in presence Colaizzi's data analysis framework protective resilience factors and barriers to resilience
Aitken (2022) Australia
National health system
Healthcare to understand the journey undergone by women, diagnosed with breast cancer, from diagnosis to survivorship, and to explore the challenges experienced by the BC survivors due to physical change, financial hardship, emotional distress and social isolation qualitative organization Pink Hope, flyers, advertising on social media, word of mouth BC survivors diagnosed for at least a year, ≥35 years diagnosed less than one year ago, diagnosed greater than 11 years prior mixed (snowball and convenience, social media and community organization advertising) Aug–Sept 2021 semi-structured interview remote (telephone or video call) thematic analysis psychological distress: process of diagnosis, undergoing treatment and isolation post-treatment
Marshall (2022) USA
Private health system
Supportive care in cancer to explore the cancer treatment–specific medication beliefs among women undergoing active cancer treatment for metastatic breast cancer qualitative designated cancer center located in southern United States metastatic BC, ≥18 years, English speaking, receiving active cancer treatment, able to complete interviews via telephone or Zoom ·· purposive ·· semi-structured interview remote (telephone or video call) thematic analysis positive cancer treatment–specific medication beliefs highlighting
the benefit of treatment, negative cancer treatment–specific medication beliefs that caused concern for cancer treatment, dialectical cancer treatment–specific medication beliefs indicating the benefits of cancer treatment outweigh the risks
Prabandari (2022) Indonesia
Poorly institutionalized system
The Breast to explore the narratives of patients with BC to understand their experiences of accessing and receiving care from diagnosis and undergoing cancer treatments qualitative Dr. Sardjito Hospital, Yogyakarta, Indonesia metastatic breast cancer, not deemed too ill, had been recruited to the parent study within 12 months prior to data collection ·· purposive (from a parent study) Jun–Nov 2019 semi-structured interview In presence thematic analysis early experiences, prior to accessing health care, navigating the system to access treatment, enduring chemotherapy and advancing disease, with crucial family support, seeking normalcy and belief in treatment
Agha (2021) Pakistan
Poorly institutionalized system
Journal of International Women's Studies to extend knowledge about the hurdles that bar BC patients from accessing the treatment and how patients and their families negotiate with the barriers led by BC qualitative ·· women suffered from BC during past five years, belonged to rural or less privileged areas of Sindh province ·· mixed (purposive and snowball) ·· semi-structured interview ·· thematic analysis knowledge, geographical, and financial barriers
Gharzai (2021) USA
Private health system
JCO Oncology Practice to characterize patients' experiences of financial toxicity in the context of an established framework to identify knowledge gaps and strategies for mitigation qualitative participants who received aid from The Pink Fund, Michigan actively undergoing BC treatment, who worked at the time of diagnosis, experienced loss of income, had a household income ≤500 % of federal poverty level ·· purposive Feb–May 2020 semi-structured interview remote (telephone or video call) thematic analysis and framework method objective burden: direct and indirect costs; subjective distress: material, psychosocial, and behavioral; novel addition to financial toxicity framework; gaps identified
Lewis (2021) Australia
National health system
Social Science & Medicine to explore how women with incurable breast cancer experience and give meaning to choice in relation to their health (and beyond) in their daily lives qualitative ·· women living with metastatic BC, Australian, ≥18 years ·· mixed (purposive and a community recruitment strategy) Aug 2017–Jan 2020 semi-structured interview mixed (remote or in presence) constructionist approach to thematic analysis ‘choice’ as relational: the interpersonal dynamics of individuals' choices; the temporal tussle surrounding decisions of daily (and future) living; circumscribed choice/delimited agency
Oshima (2021) USA
Private health system
JCO Oncology Practice to further characterize patient-reported financial experiences related to breast cancer treatment through analyzing rich qualitative data and using quantitative data to sort, stratify, and further contextualize participants' open-ended responses mixed methods Foundation Love Research Army and the Sisters Network of North Carolina women with a prior diagnosis of BC, ≥18 years, living in the United States male patients and those living outside the USA convenience Jan–Jun 2017 semi-structured interview web-based survey content analysis financial impact due to direct costs for medical care; the financial arc and long-term impacts; discordance in stated financial burden; financial impact because of indirect costs; cost transparency and communication; navigating insurance
Chebli (2020) USA
Private health system
Support Care Cancer to identify individual-, interpersonal-, community-, and organizational/healthcare policy-level factors that could contribute to financial toxicity among Latina breast cancer survivors qualitative Community of Chicago diagnosis of invasive BC, receipt of a lumpectomy or mastectomy within the past five years, self-identification as being Latina, Hispanic, or Chicana, ≥18 years ·· convenience Feb–Sept 2018 focus group in presence content analysis with deductive (theory-derived themes) and inductive approaches (themes emerging from iterative analysis) individual-level: lack of knowledge and prioritization regarding financial aspects of care; interpersonal-level: social networks as important platforms for disseminating information; community-level: community norms and dynamics as important barriers; organizational-level: financial assistance programs' restrictive eligibility criteria, lack of coverage post-treatment, limited availability, and instability
Iddrisu (2020) Ghana
Poorly institutionalized system
Nursing Open to explore the socioeconomic impact of breast cancer treatment and care on young women in Ghana qualitative three different hospitals diagnosed with BC, undergone some form of treatment, 15–49 years, living in the Accra Metropolis, speak English and Twi newly diagnosed patients and acutely sick patients on admission mixed (purposive and snowball sampling) ·· semi-structured interview in presence content analysis perceptions and beliefs, economic concerns, and secrecy
Kong (2020) Malaysia
National health system
The Oncologist to gain an in-depth understanding of the financial needs following diagnosis of breast cancer in a middle-income setting with universal health coverage, with a focus on health costs, non-health costs, employment and earnings, and financial assistance qualitative five hospitals in Malaysia, of which two public and three private hospitals Malaysian BC patients who were diagnosed at least 1 year prior to the study Patients with carcinoma in situ and recurrent cancer convenience ·· focus group in presence thematic analysis health costs, non-health costs, employment and earnings, financial assistance
Dean (2019)
SCC
USA
Private health system
Support Care Cancer to compares out-of-pocket costs for breast cancer survivors with and without lymphedema, integrating qualitative data to offer insight into what makes costs different comparing those with or without lymphedema mixed methods participants were recruited among participants in the quantitative study women with stages I–III invasive breast cancer, completion of active breast cancer treatment, >1 lymph node removed, and current residents of Pennsylvania or New Jersey active cancer or who were pregnant or planning to become pregnant in the next 6 months purposive ·· semi-structured interview in presence Thematic coding economic burden is
cumulative and cascades over time; lymphedema care needs are
unlikely to be covered by insurance; productivity losses have
long-term impact
Dean (2019)
Cancer
USA
Private health system
Cancer to provide a broader assessment of patient-driven recommendations by including diverse perspectives across age, insurance status, and race of BC survivors mixed methods participants were recruited among participants in the quantitative study women with stages I–III invasive breast cancer, completion of active breast cancer treatment, >1 lymph node removed, and current residents of Pennsylvania or New Jersey. active cancer, or who were pregnant or planning to become pregnant in the next 6 months purposive ·· semi-structured interview in presence Thematic coding expanding affordable insurance and insurance-covered items, especially
for lymphedema treatment (among the 60 % who reported lymphedema); supportive domestic help; financial assistance from diagnosis
through treatment; and employment-preserving policies
Japhet (2019) Nigeria
Poorly institutionalized system
Journal of Solid Tumors to study the physical, financial, psychological and social impacts of BC on women in Northern Nigeria in order to add more knowledge to the existing literature which could be used as a reference tool for body of academia qualitative Federal Teaching Hospital Gombe and State specialist hospital Gombe women diagnosed with BC, 18–75 years, any stage of the disease, at all the stages of treatment, from all the socio-economic background ·· purposive ·· semi-structured interview ·· thematic analysis body problems, cost of treatment, emotional disturbances, relationship
Nolan (2019) USA
Private health system
Ethnicity & Health to describe the lived experience of survivorship among young African American women who completed active treatment for breast cancer qualitative metropolitan and surrounding areas of Birmingham (Alabama), New Orleans (Louisiana), Jackson (Mississippi) premenopausal African American women who completed active treatment for BC previous diagnosis of cancer purposive ·· mixed (semi-structured interviews, field and reflective notes, and personal effects) mixed (remote or in presence) transcendental phenomenology actively managing spiritual self, actively
managing physical self, actively managing psychological self,
actively managing social self, and seeking survivorship
knowledge
Pisu (2019) USA
Private health system
Annals of Internal Medicine to explore the perspectives of patients and medical and nonmedical cancer center staff on costs of care conversations qualitative University of Alabama at Birmingham (UAB) Comprehensive Cancer Center BC survivors, ≥60 years, cancer treatment at the UAB Comprehensive Cancer Center within the previous 5 years, English-speaking, physically and mentally able to participate, and residence in the Birmingham area ·· purposive ·· semi-structured interview in presence constant
comparative method
content (reassurance, action, do not want to hear), timing (after diagnosis, when patient is ready), person (not the physician), characteristic (have time, compassionate, god communicator, knowledgeable)
McEwan (2014) Egypt
Poorly institutionalized system
Cancer Nursing to deepen our understandings of women's experiences with and interpretations of, diagnosis and treatment delays and highlight nuances not identifiable in the quantitative study mixed methods participants were recruited among participants in the quantitative study ·· ·· convenience (participants were recruited among participants in the quantitative study) ·· semi-structured interview ·· thematic and content analysis interpersonal relationships, institutional factors, public policy factors
Klimmek (2010) USA
Private health system
Clinical Journal of Oncology Nursing to use a secondary analysis of data to explore the insurance-related and financial challenges reported by women enrolled in a Managed Care Organization during and after treatment for breast cancer qualitative (longitudinal) teaching hospitals and community cancer centers in the southern United States ≥18 years, capable of comprehending written and spoken English, and enrolled in a managed care organization for at least one year ·· purposive ·· semi-structured interview (multiple) in presence Phenomenological hermeneutic analysis interacting with managed care organizations, understanding written information, obtaining authorizations, paying bills and planning for the costs of care, difficulty obtaining assistance
with insurance-related tasks
Darby (2009) USA
Private health system
Journal of Health Care for the Poor and Underserved to explore the financial burden of breast cancer on African American medically underserved women, with the ultimate aim of developing a culturally sensitive understanding about the social and economic stressors minority women face when diagnosed with breast cancer qualitative Cancer support and treatment programs across Tennessee and flyers at various treatment centers and community organizations African American women who were BC survivors ·· ·· ·· focus group ·· grounded theory lack of insurance or inadequate insurance
resulted in missed, delayed, or fewer treatment opportunities; financial burden
was not limited to the acute treatment phase; economic
hardship resulting from this disease into long-term survivorship
Lauzier (2005) Canada
National health system
Psycho-Oncology to describe and better understand how the woman and her caregiver conceptualized their experience of costs from breast cancer qualitative through health professionals in the three participating treatment centers of Montreal, Quebec City and Baie-Comeau newly diagnosed with non-metastatic BC in the 18 months prior to the focus group study ·· purposive ·· focus group in presence thematic content analysis patients' and caregivers' conceptualization of costs; sources of costs

Table 2 reports the data on 1080 participants included in this systematic review. Fifteen studies described the ethnicity of 766 respondents (75.8 %): between 52.5 % [47,48] and 94.0 % of participants [60] were non-Hispanic White/Caucasian patients, while between 4.3 % [56] and 43.0 % of participants [57,59] were non-Hispanic Black patients. Other ethnicities represented were Latina/Hispanic [45,49,54,59], Chinese [41], Malay [41], Indian [41], Asian [49,53], and Pacific Islander [54].

Table 2.

Participants’ characteristics.

First author Participants Age mean (SD), median (range), (%), (n) Ethnicity Education Level Children Marital status Income Stage of disease Years since diagnosis Treatments Employment status Insurance type
Ko (2025) 21 50·7 Hispanic/Latina = 100·0 % less than high school = 52·4 % ·· unmarried = 40·9 %
married/committed relationship = 57·1 %
$25,000 or less = 57·1 %
$25,000 to $40,000 = 23·8 %
$40,000 or more = 19·1 %
1 = 23·8 %
2 = 33·3 %
3 = 23·8 %
4 = 9·5 % don't know = 9·5 %
within 1 = 23·8 %
1-3 = 47·6 %
3-5 = 28·6 %
S = 95·0 %
RT = 47·6 %
CT = 61·9 %
·· Medi-Cal = 76·2 %
Medicare = 19·0 %
Private = 19·0 %
Other = 9·5 %
Marshall (2025) 16 55·6 (mean) White = 88·0 % non-Hispanic = 94·0 % bachelor's degree or higher = 82·0 % ·· never married = 6·0 %
married = 75·0 %
divorced = 13·0 %
widowed = 6·0 %
<50,000 = 19·0 % ·· ·· ·· ·· ··
Do (2024) 33 46 (mean)
26–62 (range)
·· primary school = 36·4 %
lower secondary = 21·2 %
upper secondary = 9·1 %
vocational training = 3·0 %
college/university = 30·3 %
·· unmarried = 15·2 %
married = 72·7 %
divorced = 12·1 %
·· I = 21·2 %
II = 45·5 %
III = 9·1 %
IV = 3·0 % unknown = 24·2 %
·· MT = 90·9 %
CT = 69·7 %
RT = 42·4 %
·· ··
Jones (2024) 18 57·0 (mean) non-Hispanic White patients = 83·0 % high school = 100·0 %
master's degree/doctorate = 72·2 %
·· married/long-term relationship = 67·0 % ·· I-III = 100·0 %
IV = 0·0 %
from 3 to 24 S = 100·0 %
CT = 72·0 %
RT = 67·0 %
·· ··
Khajoei (2024) 16 30–50 years = 50·0 % ·· higher = 60·0 % ·· married = 64·0 % ·· ·· ·· ·· ·· ··
Patra (2024) 8
(participants characteristic referred to80 BC survivors who attended the quantitative phase)
48 (40·5–56·5) ·· primary = 3·7 %
secondary = 18.7 %
college = 77·5 %
·· Married = 83·7 %
Unmarried = 5·0 %
Divorced/separated/widowed = 11·3 %
Median Rupees = 40,000 metastatic = 23·7 %
Non-metastatic = 76·2 %
>5 = 21·2 %
≤5 = 78·7 %
·· employed = 48·7 %
housewife = 51·2 %
yes = 33·7 %
no = 66·2 %
Ruan (2024) 29 35·1 (29–40) ·· middle or vocational school = 10·3 %
high school or junior college = 13·8 %
bachelor's degree = 51·7 %
master degree = 24·1 %
0 children = 37·9 %
1 child = 48·3 %
≥2 children = 13·8 %
married = 79·3 %
unmarried = 20·7 %
·· I = 24·1 %
II = 41·4 %
III = 31·1 %
IV = 3·4 %
<1 = 38·0 %
1-3 = 31·0 %
>3 = 31·0 %
S = 100·0 %
CT = 89·7 %
RT = 79·3 %
HT = 51·7 %
TT = 27·6 % traditional Chinese therapy = 31·0 %
·· ··
Waters (2024) 11
9 = patients
2 = caregivers
mean 50·5 (range = 28–65) non-Hispanic Black patients = 27·3 %
non-Hispanic White patients = 72·7 %
·· ·· ·· ·· ·· mean of 3·1 years prior to the interview (range = 1–9) S = 63·6 %
CT = 100·0 %
RT = 81·8 %
HT = 63·6 % other cancer therapies = 45·5 %
·· private insurance = 72·7 %
public insurance = 36·4 %
Khazi (2023) 12 47·7 (6·5) ·· illiterate = 8·3 %
primary = 16·7 %
high school = 50·0 %
graduate = 25·0 %
·· separated = 16·7 %
married = 75·0 %
widow = 8·3 %
·· I = 8·3 %
II = 41·7 %
III = 50·0 %
·· ·· housewife = 83·3 %
accountant = 8·3 %
bank employee = 8·3 %
··
Kolawole (2023) 21 31-40 = 28·6 %
41-50 = 28·6 %
51-60 = 4·8 %
61-70 = 38·1 %
·· non-formal = 9·5 %
primary = 19·0 %
secondary = 28·6 %
tertiary = 42·9 %
·· single = 4·8 %
married = 81 %
widow = 14·2 %
·· ·· ·· ·· full housewife = 4·8 %
civil servant = 42·0 %
artisan = 4·8 %
unemployed = 0·0 %
private organization = 4·8 %
others = 42·9 %
··
Lee (2024) 50 49·6 (11, range 31–77)
≤40 years = 40 %
Black = 34·0 %
White = 66·0 %
·· ·· ·· ·· ·· ·· ·· ·· private = 66·0 %
Medicaid = 14·0 %
Medicare = 14·0 % other/self-pay = 6·0 %
Neilson (2023) 68 <45 years = 27·9 %
45-62 = 57·4 %
>62 = 14·7 %
White or Caucasian = 89·7 %
Hispanic = 1·5 % black or African American = 4·4 %
pacific islander = 2·9 %
other = 1·5 %
never received high school diploma = 1·5 %
high school diploma = 4·4 %
trade/technical/vocational training = 2·9 %
some college level credits or associates degree = 22·1 %
bachelor's degree = 36·8 %
master's degree = 25·0 %
PhD or other advanced degree = 7·4 %
none = 29·4 %
≤2 = 58·8 %
>2 = 11·8 %
single = 17·7 %
married = 60·3 %
divorced = 8·8 %
in relationship = 4·4 %
separated = 2·9 %
widowed = 5·9 %
≤ $30,000 = 10·3 %
$30,001-$60,000 = 22·1 %
$60,001-$90,000 = 20·6 %
>$90,000 = 41·1 % no response = 5·9 %
·· ·· ·· employed = 66·2 %
disabled = 4·4 %
retired = 14·7 %
not employed/seeking work = 10·3 %
not employed/not seeking work = 4·4 %
private = 70·6 %
Medicare = 8·8 %
Medicaid = 8·8 % self-Pay = 5·9 %
none = 1·5 %
other = 4·4 %
Walton (2023) 14 57·1 (mean) ·· ·· ·· ·· ·· ·· ·· S = 100·0 %
S, CT and RT = 78·6 %
homemakers = 78·6 % ··
Aitken (2022) 15 Mean 45
35-39 = 26·6 %
40-45 = 20,0 %
46-49 = 6·6 %
50-55 = 13·3 %
56-60 = 13·3 %
·· high school = 26·6 %
diploma = 26·6 %
graduate certificate = 6·7 %
undergraduate = 13·3 %
postgraduate = 26·6 %
0 child = 6·7 %
1-2 = 53·3 %
3-4 = 33·3 %
married = 80·0 %
divorced = 6·7 %
single = 6·7 %
de-facto = 6·7 %
20,000–50,000 = 13·3 %
50,000–100,000 = 26·6 %
100,000–150,000 = 6·7 %
150,000–200,000 = 26·6 %
>200,000 = 20 %
·· ·· ·· employed = 66·0 %
unemployed = 33·3 %
full-time = 20·0 %
part-time/casual = 46·0 %
··
Marshall (2022) 16 55·6 (mean) Caucasian = 88·0 %
Black/African American = 6·0 %
Asian = 6·0 %
high school diploma = 6·0 %
associate degree = 12·0 %
bachelor's degree = 38·0 %
graduate or professional degree = 44·0 %
·· never married = 6·0 %
married = 75·0 %
divorced = 13·0 %
widowed = 6·0 %
< $24,999 = 12·5 %
$25,000 to 49,999 = 6 %
$50,000 to 99,999 = 38·0 %
$100,000 to 149,999 = 25·0 %
≥ $150,000 = 12·5 % refused = 6·0 %
·· 1–3 years = 37·5 %
4–9 = 31·0 %
10–15 = 19 %
15 = 12·5 %
Talazoparib = 12·5 %
Fulvestrant = 19·0 %
Denosumab = 19·0 %
Paclitaxel = 31·0 %
Carboplatin = 12·5 %
Abemaciclib = 6·0 %
Letrozole = 12·5 %
Palbociclib = 19·0 %
Pertuzumab = 12·5 %
Trastuzumab = 12·5 %
Exemestane = 6·0 %
Sacituzumab = 6·0 %
Gemcitabine = 6·0 %
Vinorelbine = 6·0 %
Capecitabine = 6·0 %
currently employed = 38·0 %
not employed = 62·0 %
··
Prabandari (2022) 20 40-49 = 50·0 %
50-59 = 30·0 %
60-69 = 20·0 %
·· primary/junior high school = 70·0 %
senior high school/university = 30·0 %
0 = 5·0 %
1 = 15·0 %
2 = 60·0 %
≥3 = 20·0 %
single = 5·0 %
widowed = 5·0 %
married = 90·0 %
·· III = 15·0 %
IV = 85·0 %
0 year = 30·0 %
1 = 60·0 %
3 = 10·0 %
·· housewife = 50·0 %
employed/self-employed = 45·0 %
unemployed = 5·0 %
··
Agha (2021) 42 18–37 years = 31·0 %
38-52 = 52·4 %
53-62 = 16·7 %
·· none = 23·8 %
primary = 26·2 %
secondary = 11·9 %
higher secondary = 14·3 %
graduate = 23·8 %
·· ·· ·· ·· ·· ·· ·· ··
Gharzai (2021) 32 45·9 (11·8) White = 58·1 %
Black = 25·8 %
Hispanic = 9·7 %
Asian = 6·5 % not reported = 3·1 %
less than bachelor's degree = 34·3 %
bachelor's degree = 56·3 %
more than bachelor's degree = 9·4 %
··
53·1 % had persons who required financial support
··
53·1 % were sole breadwinner
< $25,000 = 25·0 %
$25,000-$50,000 = 31·3 %
$50,000-$75,000 = 21·9 %
> $75,000 = 21·9 %
·· ·· ·· full-time = 3·1 %
part-time = 18·8 %
self-employed = 3·1 %
disability = 25·0 %
FMLA or sick leave = 31·3 % unemployment = 18·8 %
employer = 34·4 %
Medicaid or Medicare = 12·5 % private = 3·1 %
not reported = 50·0 %
Lewis (2021) 38 36–74 (mean 57·3, median 57·5) most participants were Australian born and of European decent participants across a variety of educational attainment ·· ·· ·· IV = 100 % participants across a variety of length of time since diagnosis (<1–23 years) ·· ·· private health insurance = 47·0 %
public health system insurance = 37·0 %
mixed public and private health insurances = 13·0 %
Oshima (2021) 511 answered to the survey· (313 respondents wrote about financial burden) 50·0 (26·1–76·4) 463 White and/or Caucasian (90·6 %)
22 Black and/or African American (4·3 %)
23 Other or more than one race (4·5 %)
3 Prefer not to answer (0·6 %)

111 = Up to an Associate's degree (21·7 %)
159 = College graduate (4 y) (31·1 %)
241 = Graduate education (47·2 %)
·· 376 = Married or living with partner (73·6 %)
133 = Widowed, divorced, or single (26·3 %)
2 = Prefer not to answer (0·4 %)
157 = Up to $74,000 (30·7 %)
151 = between $74,001-$125,000 (29·6 %)
140 = over $125,000 (27·4 %)
63 = Prefer not to answer (12·3 %)

0 = 83 (16·2 %)
1 = 189 (37·0 %)
2 = 153 (29·9 %)
3 = 55 (10·8 %)
4 = 9 (1·8 %) 22 = Unknown (4·3 %)
346 = <10 y (67·7 %)
146 = ≥10 y (30·5 %) 9 = Missing (1·8 %)
S = 95·0 % CT = 60·7 %
RT = 62·0 %
Current 280 = Employed full- or part-time (54·8 %)
230 = Not employed for pay (includes students and retirees) (45·0 %)
1 = Prefer not to answer (0·2 %)

343 = Private (67·1 %) 142 = Medicare (27·8 %)
26 = Other insurance (5·1 %)
Chebli (2020) 19 18–50 years = 22·0 %
≥51 = 78·0 %
19 = Latina (100 %·0) high school = 47·0 %
high school or more = 47·0 %
missing = 5·0 %
·· married = 63·0 %
not married = 37·0 %
< $30,000 = 53·0 %
$30,000 or more = 32·0 % missing = 15·0 %
·· 0–2 years = 32·0 %
3–5 = 53·0 %
6–11 = 10·0 % missing = 5·0 %
S = 100·0 % also CT only = 5·0 %
also RT only = 17·0 %
also HT only = 28·0 %
combination of therapies besides S = 39·0 %
·· insured = 67·0 %
not insured = 33·0 %
Iddrisu (2020) 12 35·9 (5·6, range 32–45) ·· junior high school = 16·7 %
senior high school = 25·0 %
tertiary = 58·3 %
0 children = 16·6 %
1 child = 41·6 %
≥2 children = 41·6 %
married = 50·0 %
single = 41·6 %
divorced = 8·3 %
·· ·· 7–48 months MT = 50·0 %
CT = 66·7 %
HT = 25·0 %
RT = 8·3 %
employed = 100·0 % ··
Kong (2020) 64 49·0 (median)
<40 years = 17·2 %
40–59 = 75·0 %
≥60 = 7·8 %
Malay = 40·6 %
Chinese = 45·3 %
Indian = 14·1 %
primary = 7·8 %
secondary = 51·6 %
tertiary = 40·6 %
·· single = 6·3 %
married = 79·7 %
other = 14·1 %
< $1045 per month = 51·6 %
$1045–$2306 per month = 26·6 %
> $2306 per month = 21·9 %
·· at least 1 year (eligibility criteria) ·· ·· self-pay/private = 58·7 %
employer = 67·4 %
none = 28·1 %
Dean (2019)
SCC
40 64 (8) 17 = Black (42·5 %)
2 = Other (5·0 %)
21 = White (52·5 %)
19 = high school (47·5 %)
12 = college (30·0 %)
9 = graduate school (22·5 %)
·· ·· 4 = ≤$30,000 (10·5 %)
22 = $30,001-$70,000 (57·8 %)
12= >$70,000 (31·6 %)
10 = 0 (32·3 %)
9 = 1 (29·0 %)
7 = 2 (22·6 %)
5 = 3 (16·1 %)
9 = missing (22·5 %)
Mean 12 years (SD ± 5) RT = 82·5 %
CT = 76·9 %
HT = 25·0 % lymphedema, +BCRL = 60·0 %
·· 12 = public (30·0 %)
33 = private (82·5 %)
0 = none (0·0 %)
Dean (2019)
Cancer
40 64 (8) 17 = Black (42·5 %)
2 = Other (5·0 %)
21 = White (52·5 %)
19 = high school (47·5 %)
12 = college (30·0 %)
9 = graduate school (22·5 %)
·· ·· 4 = ≤$30,000 (10·5 %)
22 = $30,001-$70,000 (57·8 %)
12= >$70,000 (31·6 %)
10 = 0 (32·3 %)
9 = 1 (29·0 %)
7 = 2 (22·6 %)
5 = 3 (16·1 %)
9 = missing (22·5 %)
Mean 12 years (SD ± 5) RT = 82·5 %
CT = 76·9 %
HT = 25·0 % lymphedema, +BCRL = 60·0 %
·· 12 = public (30·0 %)
33 = private (82·5 %)
0 = none (0·0 %)
Japhet (2019) 22 50·5 (15·8) ·· none = 54·5 %
primary = 18·2 %
secondary = 18·2 %
tertiary = 9·1 %
·· ·· ·· II = 9·1 %
III = 9·1
IV = 81·8 %
1 year = 13·6 %
2 = 36·4 %
3 = 9·1 %
4 = 18·2 %
5 = 22·7 %
·· ·· ··
Nolan (2019) 15 28-42 (mean 35·0) ·· some college = 16·0 %
bachelor's degree = 60·0 %
graduate degree = 27·0 %
at least one = 73·0 % single/divorced = 60·0 %
married/partnered = 40·0 %
<30 K = 33·0 %
30,001–50 K = 33·0 %
50,001–70 K = 27·0 %
>70 K = 7·0 %
·· ··
On average, participants completed active treatment 3·2 years prior to the time of study
S = 100·0 %
CT = 73·0 %
RT = 80·0 %
HT = 27·0 %
disabled/unemployed = 33·0 %
employed part-time = 7·0 %
employed full-time = 60·0 %
··
Pisu (2019) 42 60–64 years = 71·0 %
65-69 = 14·0 %
≥70 = 14·0 %
African American = 43·0 %
White = 57·0 %
high school = 17·0 %
1–3 years' college = 40·0 %
≥4 years' college = 43·0 %
·· ·· <$25 000 = 33·0 %
$25 000 to <$50 000 = 12·0 %
$50 000 to <$75 000 = 29·0 %
≥$75 000 = 29·0 % missing = 5·0 %
·· ·· CT = 45·0 %
RT = 59·0 %
HT = 21·0 %
·· Medicare = 17·0 %
Commercial/private insurance = 67·0 % other = 9·0 %
no insurance = 7·0 %
McEwan (2014) 15 range 29–60 ·· university degree = 26·6 %
high school = 33·3 %
at least one = 100·0 % married = 80·0 % ·· ·· ·· ·· employed = 33·3 % (5 were on sick leave at the time of interview)
unemployed = 66·6 %
··
Klimmek (2010) 14 52·9 (mean) predominantly White high school education = 50·0 %
college education = 50·0 %
·· predominantly not married predominantly middle/high socioeconomic status ·· ·· 3 interviews were conducted at diagnosis or pretreatment
6 were conducted during treatment
13 were conducted in the follow-up period
predominantly employed either full- or part-time ··
Darby (2009) 36 50·0 (11·4)
31–45 years = 22·0 %
46-60 = 29·0 %
>60 = 50·0 %
·· ·· ·· ·· ·· ·· ·· ·· ·· ··
Lauzier (2005) 26 53·0 (mean, 28–78) ·· ·· ·· ·· annual gross family income
$10 000–19 999 = 11·5 %
$20 000–29 999 = 15·4 %
$30 000–39 999 = 11·5 %
$40 000–49 999 = 19·2 %
>$50 000 = 42·3 %
I-III = 100·0
%
IV = 0·0 %
10 months (4–16) MT = 80·8 % conservative S = 19·2 %
AD = 96·1 %
CT = 61·5 %
RT = 76·9 %
HT = 80·8 %
no = 26·9 %
employed = 61·5 %
self-employed = 11·5 %
··

S = surgery; MT = mastectomy; AD = axillary dissection; CT = chemotherapy; RT = radiotherapy; HT = hormone therapy; TT = targeted therapy.

Fifteen studies described the employments status of 601 respondents (55.6 %): employed participants were between 33.3 % [34] and 100.0 % [35,43]; homemakers were between 4.8 % [43] and 83.3 % [36]. Thirteen studies described the insurance type of 704 respondents (65.2 %): between 3.1 % [49] and 82.5 % of participants [47,48] had a private insurance, while between 30.0 % [47,48] and 37.0 % of participants [31] had a public insurance. Another type of insurance was Medicaid/Medicare (USA), reported by between 8.8 % [54] and 76.2 % of participants [59].

Fifteen studies described the treatment modality of 621 respondents (57.5 %): between 63.6 % [58] and 100 % of participants [33,37,45,50,55] underwent surgery, from 45.0 % [57] to 100.0 % of participants [58] underwent chemotherapy, from 21.0 % [57] to 80.8 % [32] did hormone therapy, and from 8.3 % [35] to 82.5 % [47,48] underwent radiotherapy.

3.1. Appraisal consideration

Appendix D reports the results of the quality assessment (p 7); all the reports clearly stated their research aims. In almost all studies, the appropriateness of the study design, recruitment strategy, and data collection methods were positively evaluated by both researchers. However, the assessment of the relationship between researchers and participants was generally lacking, as most studies did not provide sufficient detail. Ethical considerations were generally well addressed, although some studies lacked details on informed consent. Data analyses were often rated as “Can't tell” due to insufficient descriptions of the analytical process. Nevertheless, most studies explicitly and clearly presented their findings, and over half reported adequate level of generalizability.

3.2. Meta-synthesis findings

The experience of individuals with BC concerning their cancer-related FT has been described through five main themes and related subthemes: (i) the existential cost of cancer (amplified inequalities, unaffordable medical expenses, hidden daily costs, erosion of assets, restructuring working life, shared impact on the household, work as anchor or obstacle), (ii) impact of insurance complexity (complex procedures, coverage affecting treatment decisions, distrust in insurance, maintain employment-related insurance), (iii) need for timely and accessible information (informed clinical decision-making, timing and modes of communication, cost estimation, employment and insurance opportunities to mitigate costs), (iv) seeking possible help (coping strategies, informal support networks, need for financial navigator, insufficient formal support, learning to ask), (v) negotiating daily life (dependency and role loss, abandonment of plans and aspirations). We interpreted the five themes in relation to each other by building an interpretative model, which is reported in Fig. 2.

Fig. 2.

Fig. 2

Interpretative model of cancer-related FT.

3.3. The existential cost of cancer

BC diagnosis interfered in the lives of individuals across different socioeconomic backgrounds, amplifying pre-existing inequalities through sustained, unaffordable, and often perceived as unfair medical costs [54]. One of the main consequences was the erosion of personal assets and life savings [41,47] as the only possible source to cope with these expenses (and therefore to survive cancer), particularly when insurances did not guarantee the coverage of treatments. An individual with BC from the USA (private health system) said [56], “We had to use savings to cover all of the costs, ask our families for support, and constantly deal with various office billing departments” and a patient from Malaysia (national health system) reported, [41] “I am facing financial difficulties, I have to withdraw my savings to support my daily living.”

Nevertheless, inequalities stemmed not only from medical costs but also from the unexpected daily expenses, like transport and temporary housing for rural patients needing hospital access [52]. In this scenario, employment played a dual role. For some patients, it was the main anchor, the only source of income available to cover expenses, maintain insurance, or compensate for the lack of coverage [54]: “If you don't work during your treatment, you don't have resources …” (USA – private health system).

However, the amount of earnings from work may have dwindled due to employment changes after diagnosis, such as extended sickness absences or job loss [52]. Conversely, individuals' pre-diagnosis employment status was sometimes perceived as a barrier to accessing support after diagnosis, especially when individuals were at risk of job loss and had to manage work and cancer treatment [48]: “I think there are things in place for people who are very financially needy, but not really for someone who is like … I don't know what kind of classification I am, but who can still work …” (USA – private health system).

One thing was certain: patients restructured their lives (as workers but not only), with repercussions on others, especially on the closest family members. Caregivers adapted their work to take care of assistance and household chores [39]: “My husband used to work at the airport, but because of taking care of me, he quit his job and is now working nonpermanent jobs.” (Indonesia – poorly institutionalized system).

The existential costs of cancer trigger emotional turmoil, fear of financial ruin and job loss, guilt toward loved ones, and anger at the disease and society.

3.4. Impact of insurance complexity

Patients' experiences revealed a feeling of distrust in insurance, mainly due to the lack of transparency and dishonesty [50] that leads these organizations to have only one goal: to put pressure on sick patients [46] without caring about their care or privacy [51]. An individual with BC from the USA (private health system) said [50]: “But when I was going through this I had to go on disability. My disability insurance tried to mess with how much they were giving me. Yes, it was thousands of dollars.”

Disbelief was exacerbated by delays between prompt treatment and slow insurance processes [51]. Gaps in coverage, co-payments, and reimbursement left patients unprepared, as they lacked both information and financial resources [33,41,46], not to mention those who did not have insurance coverage, like a Malaysian patient (national health system) who stated [41], “Mastectomy and prosthesis comes to US$ 241, which I am quite mindful. If the prosthesis is cheaper, then I will pay for it. But since it is over US$ 241, I am willing to forego it because of costs.”

Continuing to work was often seen as the only way to retain insurance coverage, though it was not guaranteed, as it largely depended on the type of employment contract [32].

Challenging relationships and widespread distrust towards insurers led patients to make treatment choices based on coverage and financial constraints [46], reinforcing feelings of powerlessness and injustice.

3.5. Need for timely and accessible information

Patients felt overwhelmed and unprepared to face cancer's financial impact, reporting poor access to clear, timely information on direct and indirect costs [54]. An individual with BC from the USA (private health system) reported [49]: “I think that's the hardest thing for me was the stress and the burden of the financial hardship that you go through. You feel like it's never going to end.” Another patient from India (poorly institutionalized system) said [38]: “There is no information on the entire treatment; it's like you go for surgery, then they give you the estimate, then your next step is chemotherapy, then they give an estimate for chemotherapy, then similar for radiation.”

Unmet information needs caused psychological distress, including the lack of guidance regarding the consequences of work changes and the role of income in managing care and maintaining insurance [50].

Individuals with BC from the USA (private health system) acknowledge the need for timely information provision, although the optimal timing remains unclear, whether it should be in conjunction with the diagnosis (“Right from the very beginning, absolutely, as soon as you're diagnosed and you go in there”), [49] or not (“I think cancer patients get bombarded with information in the beginning”), [54] or after diagnosis but before starting treatment [57].

Patients appropriately informed on the cost-related aspects of disease were competent to make informed clinical decisions and to deal with the disease with higher self-efficacy, as reported by a Chinese patient (national health system) [33]: “After illness, I read the literature by myself, then discussed it with the doctor for the optimal treatment method, and adhered to it. I knew how to treat it and understood my own condition.” To improve their situation, individuals with BC who lacked information sought available support.

3.6. Seeking possible help

Despite the challenges, BC survivors engaged in various coping strategies to manage FT. One of the first resources they activated was maintaining a positive attitude, which is perceived as essential to navigating the financial uncertainty caused by the illness, as reported by individuals with BC from different countries: “On some days I worry … God, what am I supposed to be doing? But at the end of the day I'm optimistic” [55] (USA - private health system) and “There is not much economic pressure. I am quite confident. My illness will definitely get better in the future.” [33] (China - national health system)

Coping strategies also included a careful rebalancing of family needs according to financial priorities and prognosis [33]: “If he (son) wants something that is not related to learning, I will consider whether to buy it, unlike before when he could buy whatever he wanted … As for myself, now I basically don't buy luxury goods.” (China – national health system).

Not least, survivors must sometimes face the scenario of an unfavourable prognosis and the potential financial impact that a premature death could impose on vulnerable family members. In this context, a reorganization of family dynamics and a redefinition of roles often emerge, shaped by the need to face both financial and clinical uncertainties because, “It's like, okay, so if I have these two years left, I need to pay whatever I can to live. But on the flip side, I don't want to go on any vacations, I don't want to buy anything extra. I want to pay down as much debt as we possibly can. Because if things go sideways, I've got to leave my family in a good situation. So, it's a real razor wire that you're walking, for cancer treatment, I think.” [52] (USA – private health system).

A key aspect of coping involved learning to seek help. Survivors may turn to family, friends, and colleagues, overcoming the discomfort that admitting vulnerability can bring and building informal networks of resilience that offer both emotional and financial support [37,50], as reported by individuals with BC from different countries: “One of my friends sent a message to the classmates group, one friend said I will pay your bill, I managed with the money sent by friends.” [37] (India - poorly institutionalized system) and “We had to ask for help a lot. They did a fundraiser for me. That helped us get through a bit. Yeah, people brought us groceries and food. Having that community around to help is what enabled us to take care of those other basic needs.” [49] (USA - private health system)

Requesting assistance is also directed toward formal institutions, which requires learning to interact with administrative systems and unfamiliar procedures, often at a time when energy and attention should be focused on healing [58]: “I need help with my electricity bill. It was kind of like, well, we need proof. They said, we're sure you're telling the truth, but we need proof from your doctor that you have cancer. So, I had to leave there, go all the way down to the hospital … wait for it … and then come all the way back and get assistance. And, if you don't get it by a certain day, you miss it that month.” (USA – private health system).

Many survivors advocate for earlier and more structured communication about care costs, and describe support from dedicated professionals, such as case managers or financial navigators [48,58], as valuable in navigating resources, completing forms, and managing bureaucratic processes [45]: “I brought up the cost with every doctor I met and every time I had an appointment. My oncologist finally told me not to mention it again as she did not want my financial situation to affect her medical decisions!” (USA – private health system).

Resilience is further strengthened through broader support networks, which may include not only personal relationships but also community services and the work environment [58]: “I received things that I didn't even ask about … [social worker] signed me up for things that I wasn't even aware of. You know, so it was great to open the mail, and get a gift card for [groceries].” (USA – private health system).

The workplace, in particular, can serve as a crucial source of support in mitigating FT, offering flexibility, understanding, and protections that may significantly help BC survivors manage the economic challenges associated with their illness [33]: “No change in position, no change in salary. The workload is relatively small now; I only need to manage my subordinates, and then I can get off work when the time comes. In the past, I had to work overtime for a long time.” (China – national health system). Even though the stress may be unbearable in certain situation [35], “I get stressed up and stress is not good so I had to slow down for a while. I finally withdrew from work totally.” (Ghana – poorly institutionalized system).

3.7. Negotiating daily life

Rising costs and limited resources forced lifestyle changes and gradual loss of access to essential and non-essential goods because “I am trying to make sure that I have the money that I need to go to the doctor.” [58] (USA – private health system) Negotiation meant suffering as “I had to miss life, things with my kids and events. [54] (USA – private health system) Deprivation did not only concern the present but also the abandonment of plans for the personal and family future. Individuals with BC from the USA and China reported: “I owe so much in medical bills that I have decided not to purchase a home” [52] (USA – private health system) and “I worry about my daughter's future education and the future expenses of our family.” [33] (China – national health system) Debts and difficulties in recovering lost money create a strong economic dependence on family members and the consequent loss of role. Accessing informal financial support may be experienced with discomfort, including a perceived loss of economic independence and decision-making role within the family.

4. Discussion

This study interprets the lived experience of cancer-related FT among individuals with BC. Most of the included studies were conducted in North America, with additional research originating in South, East, and West Asia, Oceania, and Northwest Africa. Currently, there are no qualitative studies from European countries addressing cancer-related FT in individuals with BC, despite evidence of FT in high-income nations, including nearly all European countries [19]. The findings of this review underscore the transversal nature of key dimensions of cancer-related FT in individuals with BC across healthcare systems, showing that, despite structural differences, socioeconomic and cultural conditions consistently shape patients’ experiences of financial burden.

Corroborated by a recent scoping review [62], BC survivors who lived in rural areas and with lower socioeconomic status faced greater challenges in affording medical costs, including surgery or chemotherapy. An individual with BC in the USA (private health system) was forced to sell her car [54], while a Nigerian patient (poorly institutionalized system) had to sell her goat to cover medical expenses [42].

Additionally, hidden non-medical costs, such as those incurred when traveling to the most economically accessible hospital, posed a real burden on patients and families. Due to prolonged wait times within the Canadian healthcare system, a patient was compelled to seek radiation therapy treatment abroad [32]. Therefore, a patient's socioeconomic status at the time of diagnosis, as well as any changes resulting from the cancer, such as job loss, can significantly shape their experience of FT.

As medical and non-medical expenses increased, employment was often perceived as a bulwark against FT. While employment is typically assumed to ensure adequate income for daily living, savings, and insurance coverage, cancer-related challenges, such as job loss or reduced work capacity, can severely undermine an individual's financial stability. In these circumstances, individuals with BC frequently relied on personal savings to cover treatment costs or turned to alternative sources of support. This reliance on personal financial resources is particularly common in healthcare systems where patients face substantial out-of-pocket expenses due to limited welfare support [49,56].

This scenario was also reported by several Egyptian BC survivors [63] and by caregivers of Indian cancer survivors [64]. Findings from this meta-synthesis reveal that using savings to cover treatment costs was necessary but heartbreaking, as it disrupted future plans [54]. Conversely, being employed at the time of diagnosis may be disadvantageous in accessing formal support after diagnosis. In certain circumstances, individuals with BC who were already unemployed or retired at the time of diagnosis appeared to experience lower levels of FT compared to those who became unemployed because of their illness [62].

Insurance coverage played a pivotal role in shaping the lived experience of cancer-related FT. Findings from this meta-synthesis support the notion that insurance policies often influence patients' treatment decisions, leading them to consider their financial situation and coverage limitations when selecting care options. While full coverage from insurance companies appeared to protect against FT [7], several individuals only had partial coverage and thus needed co-financing, and others had no insurance coverage at all. Insurance coverage reflects the patient's socioeconomic status, exacerbating inequality in cancer care costs. Half of the included studies were mainly conducted in the USA, a country where two-thirds of the health system is based on voluntary insurance, while the government-funded support programs are for the most vulnerable subjects (ie, the elderly) [65]. Therefore, insurance coverage depends on a patient's pre-diagnosis socioeconomic status. Overall, having insurance and clear information helped patients make informed clinical decisions. However, even those who had insurance coverage reported distrust, as they felt cheated, or because the procedures were complex at a time when promptness is required [60].

To address the unexpected costs of cancer, individuals with BC requested clear cost estimates and guidance on mitigating expenses through employment and insurance. Furthermore, patient preference regarding the timing of receiving cost-related information varied, emphasizing that a standardized approach is inadequate [66]. To face the cost of cancer, individuals with BC requested and received support from family members, the workplace, social network, and the community, sometimes even through fund raising [33]. Nonetheless, they felt uncomfortable asking for help, showing their vulnerability, and interfering with other people's lives. As a matter of fact, family members of cancer survivors suffered the most the economic repercussions of cancer treatment [67]. This meta-synthesis highlighted that sometimes the informal caregiver was forced to change his/her work condition in order to assist with domestic responsibilities [39]. This life rebuilding had an impact on household incomes. Therefore, an emerging need was to receive specific support beyond the family, specifically from a manager of the economic aspects of cancer care.

FT affected both patients and their families, forcing lifestyle changes to align costs with limited income and resources. Abandoning future plans and reducing spending on essential and non-essential goods were common changes reported [52], consistent with findings from a systematic review of Indian cancer survivors [68]. Individuals with BC faced the painful choice of treatment based on affordability, leading to emotional distress, a diminished sense of autonomy in decision-making, distrust in institutions, and feelings of guilt and of being a burden.

To summarize, this meta-synthesis is the first systematic review of qualitative studies examining the broad experience of cancer-related FT from the perspective of individuals with BC across all phases of the treatment pathway. Unlike previous reviews, which focused solely on coping strategies [20], this study included global research involving participants at varying disease stages, survivorship phases, and with different ethnic background, with the aim of capturing diverse and comprehensive experiences of FT. By not restricting inclusion based on healthcare systems, the review also considered different social contexts. Although the extensive number of studies may have limited the ability to capture certain nuanced meanings, the complete database remains open for consultation.

The review reveals a key gap: a lack of original qualitative research in Europe. This is crucial, as the experience of cancer-related FT is shaped not only by treatment costs but also by country-dependent healthcare system and cultural nuances. Europe's diverse healthcare systems may shape different FT perceptions, warranting further study.

An additional insight from this meta-synthesis is the multifaceted role of employment. Work can either help or hinder individuals with BC in managing FT, affecting both pre-diagnosis socioeconomic status and insurance coverage. Insurance, in turn, influences the existential cost of illness and is tightly linked to each country's healthcare systems.

Although this meta-synthesis focused on shared experiential dimensions of cancer-related FT, studies were conducted within diverse healthcare systems. As participants may not explicitly articulate macro-structural influences on their care trajectories, contextual effects were inferred. Therefore, healthcare systems were grouped according to dominant financing and coverage mechanisms. In predominantly private health systems, participants’ narratives emphasized that FT was shaped by insurance complexity, coverage gaps, and employment-linked benefits [46,50,51,54,56]. In national health systems, it was more commonly associated with indirect and non-covered costs, income loss, and administrative burdens [[30], [31], [32],41]. In under-resourced or poorly institutionalized contexts, FT was embedded in broader social insecurity and often experienced as an existential threat affecting both individuals and their families [35,[37], [38], [39]]. Although not intended as a systematic cross-country comparison, this framing illustrates how structural conditions influence the lived experience of FT from a patient-centred perspective. Therefore, the subthemes identified should be adapted based on each country. This context dependency limits the generalizability of the findings, and results should be interpreted with appropriate caution.

To conclude, this meta-synthesis enhances our understanding of the experience of cancer-related FT among individuals with BC, particularly its impact on daily life. The interpretative model can guide healthcare and social professionals in the screening of FT by mapping the problems encountered to promote communication that includes the economic implications of cancer diagnosis. These steps may positively affect clinical decision-making and patient's adherence to treatment as well as mitigate the psychological consequences associated with FT [69].

CRediT authorship contribution statement

Sara Paltrinieri: Writing – review & editing, Writing – original draft, Visualization, Project administration, Methodology, Investigation, Formal analysis, Data curation, Conceptualization. Margherita Schiavi: Writing – review & editing, Writing – original draft, Visualization, Project administration, Methodology, Investigation, Formal analysis, Data curation, Conceptualization. Barbara Bressi: Writing – review & editing, Investigation, Formal analysis, Data curation. Angela Contri: Writing – review & editing, Investigation, Formal analysis. Martina Torreggiani: Writing – review & editing, Investigation, Data curation. Laura Bernardi: Writing – review & editing, Investigation, Data curation. Elisa Mazzini: Writing – review & editing, Investigation, Conceptualization. Maria Chiara Bassi: Writing – review & editing, Methodology, Investigation, Conceptualization. Silvia di Leo: Writing – review & editing, Methodology, Investigation, Conceptualization. Luca Ghirotto: Writing – review & editing, Methodology, Investigation, Conceptualization. Stefania Costi: Writing – review & editing, Writing – original draft, Supervision, Project administration, Methodology, Investigation, Formal analysis, Data curation, Conceptualization.

Data sharing statement

Dataset reporting first order and second order constructs extracted from each original qualitative study included in this meta-synthesis are available for consultation in an online repository (https://doi.org/10.5281/zenodo.16561567).

Funding

This study was partially supported by the Italian Ministry of Health-Ricerca Corrente Annual Program 2027.

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgments

We thank Jacqueline M. Costa for the English language editing.

Footnotes

Appendix A

Supplementary data to this article can be found online at https://doi.org/10.1016/j.breast.2026.104705.

Contributor Information

Sara Paltrinieri, Email: sara.paltrinieri@ausl.re.it.

Margherita Schiavi, Email: margherita.schiavi@ausl.re.it.

Barbara Bressi, Email: barbara.bressi@ausl.re.it.

Angela Contri, Email: angela.contri@unimore.it.

Martina Torreggiani, Email: martina.torreggiani@ausl.re.it.

Laura Bernardi, Email: laurabernardi1994@gmail.com.

Elisa Mazzini, Email: elisa.mazzini@ausl.re.it.

Maria Chiara Bassi, Email: mariachiara.bassi@ausl.re.it.

Silvia di Leo, Email: silvia.dileo@ausl.re.it.

Luca Ghirotto, Email: luca.ghirotto@ausl.re.it.

Stefania Costi, Email: stefania.costi@unimore.it.

Appendix A. Supplementary data

The following are the Supplementary data to this article:

Multimedia component 1
mmc1.docx (33.4KB, docx)
Multimedia component 2
mmc2.docx (203.1KB, docx)

References

  • 1.Bray F., Laversanne M., Sung H., et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–263. doi: 10.3322/caac.21834. [DOI] [PubMed] [Google Scholar]
  • 2.Chen S., Cao Z., Prettner K., et al. Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050. JAMA Oncol. 2023;9:465. doi: 10.1001/jamaoncol.2022.7826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Lee K.L., Eniu A., Booth C.M., MacDonald M., Chino F. Financial toxicity and breast cancer: why does it matter, who is at risk, and how do we intervene? Am Soc Clin Oncol Educ Book. 2025;45 doi: 10.1200/EDBK-25-473450. [DOI] [PubMed] [Google Scholar]
  • 4.Zafar S.Y., Peppercorn J.M., Schrag D., et al. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist. 2013;18:381–390. doi: 10.1634/theoncologist.2012-0279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Zafar S.Y., Abernethy A.P. Financial toxicity, part I: a new name for a growing problem. Oncol Williston Park N. 2013;27(80):149. 1. [PMC free article] [PubMed] [Google Scholar]
  • 6.Kent E.E., Forsythe L.P., Yabroff K.R., et al. Are survivors who report cancer‐related financial problems more likely to forgo or delay medical care? Cancer. 2013;119:3710–3717. doi: 10.1002/cncr.28262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Ngan T.T., Van Minh H., Donnelly M., O'Neill C. Financial toxicity due to breast cancer treatment in low- and middle-income countries: evidence from Vietnam. Support Care Cancer. 2021;29:6325–6333. doi: 10.1007/s00520-021-06210-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Carrera Kantarjian HM., Blinder V.S. The financial burden and distress of patients with cancer: understanding and stepping‐up action on the financial toxicity of cancer treatment. CA Cancer J Clin. 2018;68:153–165. doi: 10.3322/caac.21443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Carrera, et al. ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer. 2024. https://www.sciencedirect.com/science/article/pii/S2059702924007609?via%3Dihub [DOI] [PMC free article] [PubMed]
  • 10.Kitaw T.A., Tilahun B.D., Zemariam A.B., Getie A., Bizuayehu M.A., Haile R.N. The financial toxicity of cancer: unveiling global burden and risk factors – a systematic review and meta-analysis. BMJ Glob Health. 2025;10 doi: 10.1136/bmjgh-2024-017133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Bian J., Shen A., Yang W., Zhang L., Qiang W. Financial toxicity experienced by patients with breast cancer-related lymphedema: a systematic review. Support Care Cancer. 2023;31:354. doi: 10.1007/s00520-023-07800-9. [DOI] [PubMed] [Google Scholar]
  • 12.Berlin N.L., Abrahamse P., Momoh A.O., et al. Perceived financial decline related to breast reconstruction following mastectomy in a diverse population‐based cohort. Cancer. 2022;128:1284–1293. doi: 10.1002/cncr.34048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Coughlin S.S., Ayyala D.N., Department of Population Health Sciences, Medical College of Georgia, Augusta University, 1120 15th Street, Augusta, GA 30912, USA Financial distress among breast cancer survivors. Curr Cancer Rep. 2020;2:48–53. doi: 10.25082/CCR.2020.01.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Smith G.L., Smith B.D., Wu C.-F., et al. Financial toxicity in breast cancer patients receiving regional nodal irradiation: variation by cancer subtype. Breast. 2024;78 doi: 10.1016/j.breast.2024.103813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Riccetti N., Felberbaum R., Flock F., et al. Financial difficulties in breast cancer survivors with and without migration background in Germany—Results from the prospective multicentre cohort study BRENDA II. Support Care Cancer. 2022;30:6677–6688. doi: 10.1007/s00520-022-07074-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Organisation internationale du travail . World employment and social outlook: trends 2024. International labour office; Geneva: 2024. [Google Scholar]
  • 17.Paltrinieri S., Fugazzaro S., Bertozzi L., et al. Return to work in European cancer survivors: a systematic review. Support Care Cancer. 2018;26:2983–2994. doi: 10.1007/s00520-018-4270-6. [DOI] [PubMed] [Google Scholar]
  • 18.International Labour Organization Statistics on women. 2025. https://ilostat.ilo.org/topics/women/
  • 19.Ehsan A.N., Wu C.A., Minasian A., et al. Financial toxicity among patients with breast cancer worldwide: a systematic review and meta-analysis. JAMA Netw Open. 2023;6 doi: 10.1001/jamanetworkopen.2022.55388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Jiahui L., Xingfeng L., Lijie W., et al. Breast cancer patients' experiences of coping with financial toxicity: a systematic review and qualitative meta‐synthesis. Psychooncology. 2025;34 doi: 10.1002/pon.70075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Tong A., Flemming K., McInnes E., Oliver S., Craig J. Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ. BMC Med Res Methodol. 2012;12:181. doi: 10.1186/1471-2288-12-181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Ouzzani M., Hammady H., Fedorowicz Z., Elmagarmid A. Rayyan—A web and mobile app for systematic reviews. Syst Rev. 2016;5:210. doi: 10.1186/s13643-016-0384-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Critical Appraisal Skills Programme CASP checklist: CASP qualitative studies checklist. 2023. https://casp-uk.net/casp-tools-checklists/qualitative-studies-checklist/
  • 24.Long H.A., French D.P., Brooks J.M. Optimising the value of the critical appraisal skills programme (CASP) tool for quality appraisal in qualitative evidence synthesis. Res Methods Med Health Sci. 2020;1:31–42. [Google Scholar]
  • 25.Böhm K., Schmid A., Götze R., Landwehr C., Rothgang H. Five types of OECD healthcare systems: empirical results of a deductive classification. Health Policy. 2013;113:258–269. doi: 10.1016/j.healthpol.2013.09.003. [DOI] [PubMed] [Google Scholar]
  • 26.Wendt C., Frisina L., Rothgang H. Healthcare system types: a conceptual framework for comparison. Soc Pol Adm. 2009;43:70–90. [Google Scholar]
  • 27.Sandelowski M., Barroso J. Springer Publishing Company; New York, NY, US: 2006. Handbook for synthesizing qualitative research. [Google Scholar]
  • 28.Sandelowski M., Barroso J., Voils C.I. Using qualitative metasummary to synthesize qualitative and quantitative descriptive findings. Res Nurs Health. 2007;30:99–111. doi: 10.1002/nur.20176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Ghirotto L. Carocci editore; Roma: 2020. La systematic review nella ricerca qualitativa: metodi e strategie, 1a edizione. [Google Scholar]
  • 30.Aitken L.-A., Hossan S.Z. The psychological distress and quality of life of breast cancer survivors in Sydney, Australia. Healthcare. 2022;10:2017. doi: 10.3390/healthcare10102017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Lewis S., Kenny K., Broom A., Kirby E., Boyle F. The social meanings of choice in living-with advanced breast cancer. Soc Sci Med. 2021;280 doi: 10.1016/j.socscimed.2021.114047. [DOI] [PubMed] [Google Scholar]
  • 32.Lauzier S., Maunsell E., De Koninck M., Drolet M., Hébert-Croteau N., Robert J. Conceptualization and sources of costs from breast cancer: findings from patient and caregiver focus groups. Psychooncology. 2005;14:351–360. doi: 10.1002/pon.851. [DOI] [PubMed] [Google Scholar]
  • 33.Ruan J., Liu C., Yang Z., et al. Suffering and adjustment: a grounded theory of the process of coping with financial toxicity among young women with breast cancer. Support Care Cancer. 2024;32:96. doi: 10.1007/s00520-024-08305-9. [DOI] [PubMed] [Google Scholar]
  • 34.McEwan J., Underwood C., Corbex M. “Injustice! that is the cause”: a qualitative study of the social, economic, and structural determinants of late diagnosis and treatment of breast cancer in Egypt. Cancer Nurs. 2014;37:468–475. doi: 10.1097/NCC.0000000000000118. [DOI] [PubMed] [Google Scholar]
  • 35.Iddrisu M., Aziato L., Ohene L.A. Socioeconomic impact of breast cancer on young women in Ghana: a qualitative study. Nurs Open. 2021;8:29–38. doi: 10.1002/nop2.590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Khazi F., Angolkar M., Bhise R., Ahmed I. Psychosocial impact at diagnosis and coping strategies among women with breast cancer-A qualitative study. Clin Epidemiol Glob Health. 2023;22 [Google Scholar]
  • 37.Walton M., Lee P. Lived experience of adult female cancer survivors to discover common protective resilience factors to cope with cancer experience and to identify potential barriers to resilience. Indian J Palliat Care. 2023;29:186–194. doi: 10.25259/IJPC_214_2022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Patra A., deSouza R., Nag S., et al. Burden of financial hardship among breast cancer survivors in Maharashtra, India. Cureus. 2024 doi: 10.7759/cureus.61625. published online June 3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Prabandari Y.S., Hartanti W., Syafriani, et al. “Alas … my sickness becomes my family's burden”: a nested qualitative study on the experience of advanced breast cancer patients across the disease trajectory in Indonesia. Breast. 2022;63:168–176. doi: 10.1016/j.breast.2022.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Khajoei R., Azadeh P., ZohariAnboohi S., Ilkhani M., Nabavi F.H. Breast cancer survivorship needs: a qualitative study. BMC Cancer. 2024;24:96. doi: 10.1186/s12885-024-11834-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Kong Y.-C., Wong L.-P., Ng C.-W., et al. Understanding the financial needs following diagnosis of breast cancer in a setting with universal health coverage. Oncologist. 2020;25:497–504. doi: 10.1634/theoncologist.2019-0426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Japhet J.H., Hamina D., Pauline D.J.S., et al. Assessment of the impact of breast cancer on women in Gombe State, Northeastern Nigeria. J Solid Tumors. 2019;9:33. [Google Scholar]
  • 43.Kolawole R.E., Muhammad F.A., Adeola R.S., Olorunfemi O., Akpor O.A. Lived experiences of breast cancer survivors at the general hospital Ilorin Kwara State Northcentral, Nigeria. Afr J Reprod Health. 2023;27:90–98. doi: 10.29063/ajrh2023/v27i6s.11. [DOI] [PubMed] [Google Scholar]
  • 44.Agha N., Tarar M.G., Rind R.D. Vol. 22. 2021. (Exploring breast cancer patients' experiences of struggle against socio-economic and geographical barriers in rural Pakistan). [Google Scholar]
  • 45.Chebli P., Lemus J., Avila C., et al. Multilevel determinants of financial toxicity in breast cancer care: perspectives of healthcare professionals and Latina survivors. Support Care Cancer. 2020;28:3179–3188. doi: 10.1007/s00520-019-05119-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Darby K., Davis C., Likes W., Bell J. Exploring the financial impact of breast cancer for African American medically underserved women: a qualitative study. J Health Care Poor Underserved. 2009;20:721–728. doi: 10.1353/hpu.0.0176. [DOI] [PubMed] [Google Scholar]
  • 47.Dean L.T., Moss S.L., Ransome Y., et al. “It still affects our economic situation”: long-term economic burden of breast cancer and lymphedema. Support Care Cancer. 2019;27:1697–1708. doi: 10.1007/s00520-018-4418-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Dean L.T., Moss S.L., Rollinson S.I., Frasso Jaramillo L., Paxton R.J., Owczarzak J.T. Patient recommendations for reducing long‐lasting economic burden after breast cancer. Cancer. 2019;125:1929–1940. doi: 10.1002/cncr.32012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Gharzai L.A., Ryan K.A., Szczygiel L., et al. Financial toxicity during breast cancer treatment: a qualitative analysis to inform strategies for mitigation. JCO Oncol Pract. 2021;17:e1413–e1423. doi: 10.1200/OP.21.00182. [DOI] [PubMed] [Google Scholar]
  • 50.Jones S.M., Yi J., Henrikson N.B., Panattoni L., Shankaran V. Financial hardship after cancer: revision of a conceptual model and development of patient-reported outcome measures. Future Sci OA. 2024;10:FSO983. doi: 10.2144/fsoa-2023-0229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Klimmek R., Snow D., Wenzel J. Insurance-related and financial challenges reported by managed care enrollees with breast cancer. Clin J Oncol Nurs. 2010;14:598–606. doi: 10.1188/10.CJON.598-606. [DOI] [PubMed] [Google Scholar]
  • 52.Lee S., Olvera R.G., Shiu-Yee K., et al. Short-term and long-term financial toxicity from breast cancer treatment: a qualitative study. Support Care Cancer. 2024;32:24. doi: 10.1007/s00520-023-08199-z. [DOI] [PubMed] [Google Scholar]
  • 53.Marshall V.K., Visovsky C., Advani P., Mussallem D., Tofthagen C. Cancer treatment–specific medication beliefs among metastatic breast cancer patients: a qualitative study. Support Care Cancer. 2022;30:6807–6815. doi: 10.1007/s00520-022-07101-7. [DOI] [PubMed] [Google Scholar]
  • 54.Neilson T., Huynh V., Macdonald A., et al. Financial toxicity of breast cancer care: the patient perspective through surveys and interviews. J Surg Res. 2023;281:122–129. doi: 10.1016/j.jss.2022.08.021. [DOI] [PubMed] [Google Scholar]
  • 55.Nolan T.S., Ivankova N., Carson T.L., et al. Life after breast cancer: ‘being’ a young African American survivor. Ethn Health. 2022;27:247–274. doi: 10.1080/13557858.2019.1682524. [DOI] [PubMed] [Google Scholar]
  • 56.Oshima S.M., Tait S.D., Rushing C., et al. Patient perspectives on the financial costs and burdens of breast cancer surgery. JCO Oncol Pract. 2021;17:e872–e881. doi: 10.1200/OP.20.00780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Pisu M., Schoenberger Y.-M., Herbey I., et al. Perspectives on conversations about costs of cancer care of breast cancer survivors and cancer center staff: a qualitative study. Ann Intern Med. 2019;170:S54–S61. doi: 10.7326/M18-2117. [DOI] [PubMed] [Google Scholar]
  • 58.Waters A.R., Petermann V.M., Planey A.M., et al. Financial burden among metastatic breast cancer patients: a qualitative inquiry of costs, financial assistance, health insurance, and financial coping behaviors. Cancer Causes Control. 2024;35:955–961. doi: 10.1007/s10552-024-01854-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Ko E., Valadez Galindo A., Avila M., et al. Cancer-related financial toxicity among Latinas with breast cancer in a rural area of the United States: a qualitative study. BMC Womens Health. 2025;25:182. doi: 10.1186/s12905-025-03692-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Marshall V.K., Tofthagen C., Advani P., Mussallem D., Zambroski C., Visovsky C. Qualitative evaluation of financial toxicity and supportive care needs of women with metastatic breast cancer. Nurs Res. 2025 doi: 10.1097/NNR.0000000000000831. published online April 23. [DOI] [PubMed] [Google Scholar]
  • 61.Do T.T., Whittaker A., Davis MDm. Financial struggles and coping with the aftermath of breast cancer care: an ethnographic study in Vietnam. Soc Sci Med. 2024;360 doi: 10.1016/j.socscimed.2024.117320. [DOI] [PubMed] [Google Scholar]
  • 62.Kuang Y., Yuan X., Zhu Z., Xing W. Financial toxicity among breast cancer patients: a scoping review of risk factors and outcomes. Cancer Nurs. 2025;48:e166–e173. doi: 10.1097/NCC.0000000000001262. [DOI] [PubMed] [Google Scholar]
  • 63.Gany F., Ayash C., Raad N., et al. Financial and food security challenges of Egyptian women undergoing breast cancer treatment. Support Care Cancer. 2020;28:5787–5794. doi: 10.1007/s00520-020-05426-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Mathew M., Rao A.P., Pai A., Sumit K., Lewis S. Assessment of financial toxicity and coping strategies associated with cancer treatment among caregivers of patients with cancer from a lower-Middle–Income country. JCO Glob Oncol. 2024 doi: 10.1200/GO.23.00397. [DOI] [PubMed] [Google Scholar]
  • 65.Toth F. Classification of healthcare systems: can we go further? Health Policy. 2016;120:535–543. doi: 10.1016/j.healthpol.2016.03.011. [DOI] [PubMed] [Google Scholar]
  • 66.Paltrinieri S., Cavuto S., Contri A., et al. Needs of breast cancer survivors: a systematic review of quantitative data. Crit Rev Oncol Hematol. 2024;201 doi: 10.1016/j.critrevonc.2024.104432. [DOI] [PubMed] [Google Scholar]
  • 67.Fitch M.I., Longo C.J. Emerging understanding about the impact of financial toxicity related to cancer: canadian perspectives. Semin Oncol Nurs. 2021;37 doi: 10.1016/j.soncn.2021.151174. [DOI] [PubMed] [Google Scholar]
  • 68.Boby J.M., Rajappa S., Mathew A. Financial toxicity in cancer care in India: a systematic review. Lancet Oncol. 2021;22:e541–e549. doi: 10.1016/S1470-2045(21)00468-X. [DOI] [PubMed] [Google Scholar]
  • 69.Halpern M.T., Thamm C., Knowles R., Chan R.J. Cancer survivors' experience of care and financial toxicity: results from a national survey. JCO Oncol Pract. 2025;21:226–234. doi: 10.1200/OP.24.00370. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Multimedia component 1
mmc1.docx (33.4KB, docx)
Multimedia component 2
mmc2.docx (203.1KB, docx)

Articles from The Breast : Official Journal of the European Society of Mastology are provided here courtesy of Elsevier

RESOURCES